return to news
  1. Sai Life Sciences IPO listing highlights: Shares close 18% higher on listing day

Market News

Sai Life Sciences IPO listing highlights: Shares close 18% higher on listing day

Upstox

3 min read | Updated on December 18, 2024, 16:18 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

The ₹3,042 crore public issue of Sai Life Science was oversubscribed 10.27x, and the allotment was finalised on Monday evening. The shares list at an 18.4% premium and jump 7% higher to hit a listing day high of ₹701 per share.

sai-life-sciences-ipo-gmp.webp

Sai Life Sciences IPO was oversubscribed by 10x with strong participation by retail investors.

Sai Life Sciences IPO listing 3:30 pm: Share price Shares of Sail Life Sciences IPO closed with handsome gains for the investors as the shares jumped nearly 16% higher from the listing price of ₹650 apiece. The

Sai Life Sciences IPO listing 2:00 pm: Share price live CMP- ₹745

Open-₹650

Low-₹650

High-₹766

Sai Life Sciences IPO listing 1:00 pm: About the company

Sai Life Sciences Limited, established in 1999, specialises in research, development and manufacturing of small-molecule new chemical entities. It provides services to biotech and global pharmaceutical companies. The company’s services span markets like the US, UK, Europe and Japan.

Sai Life Sciences offers services in chemistry, manufacturing and control (CMC), contract development and manufacturing (CDMO), and contract research organisation (CRO), covering areas like biology, chemistry and drug metabolism.

After hitting listing day high of ₹764 apiece on the NSE, shares pared some gains to trade 14.5% higher at ₹744 per share at 13:00 pm.

Sai Life Sciences IPO listing 10:00 am: Shares price live at 11:10 am

CMP- ₹750

Open-₹650

Low-₹650

High-₹764

Sai Life Sciences IPO listing 10:00 am: Shares jump 4% higher post listing Shares of Sai Life Sciences jumped 4% higher to hit new listing day high of ₹675 per share on the NSE after opening at ₹650 per share on the NSE.
Sai Life Sciences IPO listing 9:52 am: Listing Shares of Sai Life Sciences IPO to list at 18.4% premium on the NSE at ₹650 apiece against the issue price of ₹549 apiece.
Sai Life Sciences IPO listing 9:50 am: Financials Sai Life Sciences reported revenue from operations of ₹1,217.1 crore in FY23, which increased to ₹1,465.1 crore in FY24 and ₹675.29 crore for the first half of FY25. The company’s net profit stood at ₹9.98 crore in FY23, rising significantly to ₹82.80 crore in FY24, with ₹28.01 crore reported in H1FY25.
Sai Life Sciences IPO listing 9:45 am: Objective Sai Life Sciences plans to use the net proceeds from the IPO for specific purposes, which include repayment or prepayment, either in full or part, of its outstanding borrowings. In addition, the company will also use the funds for general corporate purposes.
Sai Life Sciences IPO listing:The mainboard issue was overall subscribed 10.27 times with bids for more than 39.86 crore shares, compared to the 3.88 crore shares on offer.

The qualified institutional buyers (QIBs) showed the highest demand by subscribing their quota 30.93 times, with bids for 33.01 crore shares against the 1.07 crore shares available to them. The non-institutional investors (NIIs) placed bids for 4.15 crore shares against the 84.47 lakh shares on offer, leading to a subscription of 4.92 times in the segment.

The retail segment of the IPO was subscribed 1.3 times as retail investor bid 2.69 crore shares against the offer of 1.97 crore shares.

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story